# Intraocular Pressure (IOP) Lowering Efficacy of Transdermal Latanoprost Therapy

> **NCT01426464** · PHASE2 · UNKNOWN · sponsor: **Nanduri, Padma, M.D., FACS** · enrollment: 22 (estimated)

## Conditions studied

- Glaucoma

## Interventions

- **DRUG:** 0.005% Latanoprost dosed once.

## Key facts

- **NCT ID:** NCT01426464
- **Lead sponsor:** Nanduri, Padma, M.D., FACS
- **Sponsor class:** INDIV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-09
- **Primary completion:** 2011-11
- **Final completion:** 2011-12
- **Target enrollment:** 22 (ESTIMATED)
- **Last updated:** 2011-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01426464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01426464, "Intraocular Pressure (IOP) Lowering Efficacy of Transdermal Latanoprost Therapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01426464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*